Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'LIPID ABNORMALITIES' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 145 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Holdaas, H; Fellstrom, B; Holme, I; Nyberg, G; Fauchald, P; Jardine, A; Gronhagen-Riska, C; Madser, S; Neumayer, HH; Cole, E; Maes, B; Weinreich, T; Olsson, AG; Pedersen, TR; Benghozi, R; Hartmann, A
      Effects of fluvastatin on cardiac events in renal transplant patients: ALERT (Assessment of Lescol (R) in Renal Transplantation) study design and baseline data

      JOURNAL OF CARDIOVASCULAR RISK
    2. Borderi, M; Verucchi, G; Tadolini, M; Spinosa, S; Fortunato, L; Talo, S; Chiodo, F
      Metabolic complications of HIV-1 antiretroviral therapy: The lipodystrophysyndrome

      MICROBIOLOGICA
    3. Biasioli, S; Schiavon, R; Petrosino, L; Cavallini, L; De Fanti, E; Zambello, A; Borin, D; Targa, L
      Do different dialytic techniques have different atherosclerotic and antioxidant activities?

      ASAIO JOURNAL
    4. Herman, JS; Easterbrook, PJ
      The metabolic toxicities of antiretroviral therapy

      INTERNATIONAL JOURNAL OF STD & AIDS
    5. Descamps-Latscha, B; Drueke, T; Witko-Sarsat, V
      Dialysis-induced oxidative stress: Biological aspects, clinical consequences, and therapy

      SEMINARS IN DIALYSIS
    6. Saves, M; Mercie, P; Chene, G
      Lipodystrophic syndrome and antiretroviral treatments in HIV-infected patients

      M S-MEDECINE SCIENCES
    7. Boaz, M; Green, M; Fainauru, M; Smetana, S
      Oxidative stress and cardiovascular disease in hemodialysis

      CLINICAL NEPHROLOGY
    8. Herrera, J; Nava, M; Biol, L; Romero, F; Biol, L; Rodriguez-Iturbe, B
      Melatonin prevents oxidative stress resulting from iron and erythropoietinadministration

      AMERICAN JOURNAL OF KIDNEY DISEASES
    9. Anderson, RE; Maude, MB; Bok, D
      Low docosahexaenoic acid levels in rod outer segment membranes of mice with rds/peripherin and P216L peripherin mutations

      INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
    10. Descamps-Latscha, B; Witko-Sarsat, V
      Importance of oxidatively modified proteins in chronic renal failure

      KIDNEY INTERNATIONAL
    11. Grekas, D; Kassimatis, E; Makedou, A; Bacharaki, D; Bamichas, G; Tourkantonis, A
      Combined treatment with low-dose pravastatin and fish oil in post-renal transplantation dislipidemia

      NEPHRON
    12. Tsai, JC; Sheu, HM; Hung, PL; Cheng, CL
      Effect of barrier disruption by acetone treatment on the permeability of compounds with various lipophilicities: Implications for the permeability ofcompromised skin

      JOURNAL OF PHARMACEUTICAL SCIENCES
    13. Bottari, E; Festa, MR; Apruzzese, F; Paone, A; Palumbo, R; Vitaliano, E; Bondanini, F; Moroni, C; Cassone, R
      Changes of plasma redox parameters by hemodialytic treatment in patients with chronic renal failure

      ANNALI DI CHIMICA
    14. Moulin, B; Caillard, S
      Use of statins in kidney diseases

      ANNALES D ENDOCRINOLOGIE
    15. Matthews, GV; Moyle, GJ; Mandalia, S; Bower, M; Nelson, M; Gazzard, BG
      Absence of association between individual thymidine analogues or nonnucleoside analogues and lipid abnormalities in HIV-1-infected persons on initialtherapy

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    16. Turchetti, V; Bellini, MA; Leoncini, F; Petri, F; Trabalzini, L; Guerrini, M; Forconi, S
      Blood viscosity and red cell morphology in subjects suffering from cirrhosis before and after treatment with S-Adenosyl-L-Methionine (SAM)

      CLINICAL HEMORHEOLOGY AND MICROCIRCULATION
    17. Passalaris, JD; Sepkowitz, KA; Glesby, MJ
      Coronary artery disease and human immunodeficiency virus infection

      CLINICAL INFECTIOUS DISEASES
    18. Biasioli, S; Schiavon, R; Petrosino, L; Cavallini, L; Cavalcanti, G; De Fanti, E; Zambello, A; Borin, D
      Role of cellulosic and noncellulosic membranes in hyperhomocysteinemia andoxidative stress

      ASAIO JOURNAL
    19. Hufnagel, G; Michel, C; Vrtovsnik, F; Queffeulou, G; Kossari, N; Mignon, F
      Effects of atorvastatin on dyslipidaemia in uraemic patients on peritonealdialysis

      NEPHROLOGY DIALYSIS TRANSPLANTATION
    20. Mak, RHK
      Impact of end-stage renal disease and dialysis on glycemic control

      SEMINARS IN DIALYSIS
    21. Kimak, E; Solski, J; Janicka, L
      Lipoprotein profiles at different stages of chronic renal insufficiency

      RENAL FAILURE
    22. Eiselt, J; Racek, J; Opatrny, K
      Oxidative stress: the effect of erythropoietin and the dialysis membrane

      INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS
    23. Lynn, EG; Siow, YL; O, K
      Very low-density lipoprotein stimulates the expression of monocyte chemoattractant protein-1 in mesangial cells

      KIDNEY INTERNATIONAL
    24. Mosnier-Pudar, H
      Metabolic complications associated with use of HIV protease inhibitors

      ANNALES DE MEDECINE INTERNE
    25. Moulin, P
      Vascular risk in the diabetic patient: the lipid factor. From epidemiological data to intervention trials.

      DIABETES & METABOLISM
    26. Fernandez-Miranda, C; De la Calle, A; Loinaz, C; Moreno, E
      Hyperlipidemia in liver transplanted patients.

      REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS
    27. Templar, J; Kon, SP; Milligan, TP; Newman, DJ; Raftery, MJ
      Increased plasma malondialdehyde levels in glomerular disease as determined by a fully validated HPLC method

      NEPHROLOGY DIALYSIS TRANSPLANTATION
    28. Lim, PS; Wei, YH; Yu, YL; Kho, B
      Enhanced oxidative stress in haemodialysis patients receiving intravenous iron therapy

      NEPHROLOGY DIALYSIS TRANSPLANTATION
    29. Mak, RHK
      Effect of metabolic acidosis on hyperlipidemia in uremia

      PEDIATRIC NEPHROLOGY
    30. Mocan, H; Aksoy, A; Uydu, HA; Mocan, MC
      Oxidative damage of erythrocyte membrane in nephrotic syndrome

      PEDIATRIC NEPHROLOGY
    31. Lepre, F; Rigby, R; Hawley, C; Saltissi, D; Brown, A; Walsh, ZA
      A double-blind placebo controlled trial of simvastatin for the treatment of dyslipidaemia in renal allograft recipients

      CLINICAL TRANSPLANTATION
    32. Hegbrant, J; Bengtsson, UH
      Vitamin C and E as antioxidants in hemodialysis patients

      INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS
    33. Mimic-Oka, J; Simic, T; Djukanovic, L; Reljic, Z; Davicevic, Z
      Alteration in plasma antioxidant capacity in various degrees of chronic renal failure

      CLINICAL NEPHROLOGY
    34. Yalcin, A; Kocaoglu, S; Akcicek, F; Ozyer, A
      Effects of acetate or bicarbonate dialysis solutions on serum HDL and HDL subfractions of patients undergoing haemodialysis

      CURRENT MEDICAL RESEARCH AND OPINION
    35. Boaz, M; Matas, Z; Biro, A; Katzir, Z; Green, M; Fainaru, M; Smetana, S
      Comparison of hemostatic factors and serum malondialdehyde as predictive factors for cardiovascular disease in hemodialysis patients

      AMERICAN JOURNAL OF KIDNEY DISEASES
    36. Jardine, A; Holdaas, H
      Fluvastatin in combination with cyclosporin in renal transplant recipients: a review of clinical and safety experience

      JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
    37. Wu, JM; Zhu, YH; Patel, SB
      Cyclosporin-induced dyslipoproteinemia is associated with selective activation of SREBP-2

      AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
    38. Nguyen-Khoa, T; Massy, ZA; Witko-Sarsat, V; Thevenin, M; Touam, M; Lambrey, G; Lacour, B; Drueke, TB; Descamps-Latscha, B
      Critical evaluation of plasma and LDL oxidant-trapping potential in hemodialysis patients

      KIDNEY INTERNATIONAL
    39. Haas, M; Kerjaschki, D; Mayer, G
      Lipid-lowering therapy in membranous nephropathy

      KIDNEY INTERNATIONAL
    40. Sakurai, T; Akiyama, H; Oka, T; Sekita, K; Yokono, K; Goto, T
      Serum lipids status in patients with diabetic uremia on 10 years of maintenance hemodialysis

      KIDNEY INTERNATIONAL
    41. Valdes, RH; Sonora, M
      Nonimmunologic factors in the progression of chronic dysfunction in renal allografts

      TRANSPLANTATION PROCEEDINGS
    42. Paragh, G; Asztalos, L; Seres, I; Balogh, Z; Locsey, L; Karpati, I; Matyus, J; Katona, E; Harangi, M; Kakuk, G
      Serum paraoxonase activity changes in uremic and kidney-transplanted patients

      NEPHRON
    43. Capodicasa, E; Trovarelli, G; De Medio, GE; Pelli, MA; Lippi, G; Verdura, C; Timio, M
      Volatile alkanes and increased concentrations of isoprene in exhaled air during hemodialysis

      NEPHRON
    44. Anderson, RE; Maude, MB; Alvarez, RA; Acland, G; Aguirre, GD
      A hypothesis to explain the reduced blood levels of docosahexaenoic acid in inherited retinal degenerations caused by mutations in genes encoding retina-specific proteins

      LIPIDS
    45. BIASIOLI S; SCHIAVON R; PETROSINO L; CAVALLINI L; CAVALCANTI G; DEFANTI E
      DIALYSIS KINETICS OF HOMOCYSTEINE AND REACTIVE OXYGEN SPECIES

      ASAIO journal
    46. HARRIS LM; ARMSTRONG D; BROWNE R; ALJADA A; PEER R; UPSON J; PILLAI L; CURL GR; RICOTTA JJ
      PREMATURE PERIPHERAL VASCULAR-DISEASE - CLINICAL PROFILE AND ABNORMALLIPID-PEROXIDATION

      Cardiovascular surgery
    47. HIGUERUELO S; VAQUERO M; PASTOR C; GALIMANY R; ROMERO R
      FOSINOPRIL AMELIORATES EXOGENOUS CHOLESTEROL-INDUCED INCIPIENT GLOMERULAR-LESIONS IN OBESE ZUCKER RATS - EFFECTS ON EICOSANOID SECRETION

      Nephrology, dialysis, transplantation
    48. FERNANDEZMIRANDA C; DELACALLE A; MORALES JM; GUIJARRO C; ARANDA JL; GOMEZSANZ R; GOMEZIZQUIERDO T; LARUMBE S; MORENO E; RODICIO JL; DELPALACIO A
      LIPOPROTEIN ABNORMALITIES IN LONG-TERM STABLE LIVER AND RENAL TRANSPLANTED PATIENTS - A COMPARATIVE-STUDY

      Clinical transplantation
    49. MARTINMATEO MC; DELCANTOJAFIEZ E; BARREROMARTINEZ MJ
      OXIDATIVE STRESS AND ENZYME-ACTIVITY IN AMBULATORY RENAL PATIENTS UNDERGOING CONTINUOUS PERITONEAL-DIALYSIS

      Renal failure
    50. WALSER M
      EFFECTS OF A SUPPLEMENTED VERY-LOW PROTEIN-DIET IN PREDIALYSIS PATIENTS ON THE SERUM-ALBUMIN LEVEL, PROTEINURIA, AND SUBSEQUENT SURVIVAL ONDIALYSIS

      Mineral and electrolyte metabolism
    51. GINSBURG ES; WALSH B; GREENBERG L; PRICE D; CHERTOW GM; OWEN WF
      EFFECTS OF ESTROGEN REPLACEMENT THERAPY ON THE LIPOPROTEIN PROFILE INPOSTMENOPAUSAL WOMEN WITH ESRD

      Kidney international
    52. AMBROSCH A; DOMROESE U; WESTPHAL S; DIERKES J; AUGUSTIN W; NEUMANN KH; LULEY C
      COMPOSITIONAL AND FUNCTIONAL-CHANGES OF LOW-DENSITY-LIPOPROTEIN DURING HEMODIALYSIS IN PATIENTS WITH ESRD

      Kidney international
    53. CUEVAS A; ALBERTO M; ARTEAGA A
      DYSLIPIDEMIAS IN RENAL DISEASES - PATHOGE NESIS AND TREATMENT

      Revista Medica de Chile
    54. Delton-Vandenbroucke, I; Maude, MB; Chen, HM; Aguirre, GD; Acland, GM; Anderson, RE
      Effect of diet on the fatty acid and molecular species composition of dog retina phospholipids

      LIPIDS
    55. BOFINGER A; WESTHUYZEN J; SALTISSI D; MORGAN C; HEALY H
      LOW-DENSITY-LIPOPROTEIN SUBFRACTION PROFILES IN DIALYSIS PATIENTS

      Nephrology
    56. CAPPELLI P; DILIBERATO L; STUARD S; BALLONE E; ALBERTAZZI A
      N-3 POLYUNSATURATED FATTY-ACID SUPPLEMENTATION IN CHRONIC PROGRESSIVERENAL-DISEASE

      JN. Journal of nephrology
    57. BIASIOLI S; SCHIAVON R; PETROSINO L; CAVALLINI L; ZAMBELLO A; DEFANTI E; GIAVARINA D
      FREE-RADICALS AND OXIDATIVE STRESS CHALLENGE DIALYSIS PATIENTS - EFFECTS OF 2 DIFFERENT MEMBRANES

      ASAIO journal
    58. VANBARLINGEN HHJJ; VANBEEK A; ERKELENS DW; DEBRUIN TWA
      DANAPAROID - AN ANTITHROMBOTIC AGENT WITHOUT MAJOR IMPACT ON TRIGLYCERIDE HYDROLYSIS CAPACITY IN HUMANS

      Journal of internal medicine
    59. LIANG K; VAZIRI ND
      GENE-EXPRESSION OF LDL, RECEPTOR, HMG-COA REDUCTASE, AND CHOLESTEROL-7-ALPHA-HYDROXYLASE IN CHRONIC-RENAL-FAILURE

      Nephrology, dialysis, transplantation
    60. BONNEFONTROUSSELOT D; JAUDON MC; ISSAD B; CACOUB P; CONGY F; JARDEL C; DELATTRE J; JACOBS C
      ANTIOXIDANT STATUS OF ELDERLY CHRONIC RENAL PATIENTS TREATED BY CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS

      Nephrology, dialysis, transplantation
    61. CRISTOL JP; BOSC JY; BADIOU S; LEBLANC M; LORRHO R; DESCOMPS B; CANAUD B
      ERYTHROPOIETIN AND OXIDATIVE STRESS IN HEMODIALYSIS - BENEFICIAL-EFFECTS OF VITAMIN-E SUPPLEMENTATION

      Nephrology, dialysis, transplantation
    62. BANYAIFALGER S; GOTTSAUNERWOLF M; STEPAN E; STROBL W; JANSEN M; HEINZ G
      LIPOPROTEIN PATTERN IN END-STAGE RENAL-DISEASE AND FOLLOWING SUCCESSFUL RENAL-TRANSPLANTATION

      Clinical transplantation
    63. GUCKELBERGER O; BECHSTEIN WO; NEUHAUS R; LUESEBRINK R; LEMMENS HP; KRATSCHMER B; JONAS S; NEUHAUS PL
      CARDIOVASCULAR RISK-FACTORS IN LONG-TERM FOLLOW-UP AFTER ORTHOTOPIC LIVER-TRANSPLANTATION

      Clinical transplantation
    64. DELGADORODRIGUEZ M; MEDINACUADROS M; MARTINEZGALLEGO G; SILLEROARENAS M
      TOTAL CHOLESTEROL, HDL-CHOLESTEROL, AND RISK OF NOSOCOMIAL INFECTION - A PROSPECTIVE-STUDY IN SURGICAL PATIENTS

      Infection control and hospital epidemiology
    65. SIAMOPOULOS KC; ELISAF M
      IS CAPD ATHEROGENIC

      Peritoneal dialysis international
    66. HULTQVIST M; HEGBRANT J; NILSSONTHORELL C; LINDHOLM T; NILSSON P; LINDEN T; HULTQVISTBENGTSSON U
      PLASMA-CONCENTRATIONS OF VITAMIN-C, VITAMIN-E AND OR MALONDIALDEHYDE AS MARKERS OF OXYGEN-FREE RADICAL PRODUCTION DURING HEMODIALYSIS/

      Clinical nephrology
    67. ROSS EA; KOO LC; MOBERLY JB
      LOW WHOLE-BLOOD AND ERYTHROCYTE LEVELS OF GLUTATHIONE IN HEMODIALYSISAND PERITONEAL-DIALYSIS PATIENTS

      American journal of kidney diseases
    68. LORENZO M; BETANCOR P; VEGA N; GUINDEO MC; AGUILAR JA; DELATORRE JM; MORALES A; PEREZ JCR
      LIPOPROTEIN ABNORMALITIES IN PATIENTS ON LONG-TERM HEMODIALYSIS

      Nefrologia
    69. CHEN CK; LIAW JM; JUANG JG; LINN TH
      ANTIOXIDANT ENZYMES AND TRACE-ELEMENTS IN HEMODIALYZED PATIENTS

      Biological trace element research
    70. AGUIRRE GD; ACLAND GM; MAUDE MB; ANDERSON RE
      DIETS ENRICHED IN DOCOSAHEXAENOIC ACID FAIL TO CORRECT PROGRESSIVE ROD-CONE DEGENERATION (PRCD) PHENOTYPE

      Investigative ophthalmology & visual science
    71. ARNADOTTIR M; BERG AL; DALLONGEVILLE J; FRUCHART JC; NILSSONEHLE P
      ADRENOCORTICOTROPIC HORMONE LOWERS SERUM LP(A) AND LDL CHOLESTEROL CONCENTRATIONS IN HEMODIALYSIS-PATIENTS

      Kidney international
    72. SCOPPOLA A; DEPAOLIS P; MENZINGER G; LALA A; DIGIULIO S
      PLASMA MEVALONATE CONCENTRATIONS IN UREMIC PATIENTS

      Kidney international
    73. VAZIRI ND; LIANG KH
      DOWN-REGULATION OF VLDL RECEPTOR EXPRESSION IN CHRONIC EXPERIMENTAL RENAL-FAILURE

      Kidney international
    74. KOBASHIGAWA JA; KASISKE BL
      HYPERLIPIDEMIA IN SOLID-ORGAN TRANSPLANTATION

      Transplantation
    75. ARNADOTTIR M; BERG AL
      TREATMENT OF HYPERLIPIDEMIA IN RENAL-TRANSPLANT RECIPIENTS

      Transplantation
    76. ARNADOTTIR M
      PATHOGENESIS OF DYSLIPOPROTEINEMIA IN RENAL-INSUFFICIENCY - THE ROLE OF LIPOPROTEIN-LIPASE AND HEPATIC LIPASE

      Scandinavian journal of clinical & laboratory investigation
    77. HASSE JM
      DIET THERAPY FOR ORGAN-TRANSPLANTATION - A PROBLEM-BASED APPROACH

      The Nursing clinics of North America
    78. KOSE K; DOGAN P; GUNDUZ Z; DUSUNSEL R; UTAS C
      OXIDATIVE STRESS IN HEMODIALYZED PATIENTS AND THE LONG-TERM EFFECTS OF DIALYZER REUSE PRACTICE

      Clinical biochemistry
    79. IRISH AB; SIMONS LA
      CHRONIC RENAL-DISEASE AND CARDIOVASCULAR COMPLICATIONS - INEVITABLE OR PREVENTABLE - NOW IS THE TIME FOR SOME INTERVENTION STUDIES

      Australian and New Zealand Journal of Medicine
    80. ELISAF M; MIKHAILIDIS DP; SIAMOPOULOS KC
      DYSLIPIDEMIA IN PATIENTS WITH RENAL DISEASES

      Journal of drug development and clinical practice
    81. BIASIOLI S; SCHIAVON R; DEFANTI E; CAVALCANTI G; GIAVARINA D
      THE ROLE OF ERYTHROCYTES IN THE DEPEROXIDATIVE PROCESSES IN PEOPLE ONHEMODIALYSIS

      ASAIO journal
    82. MASSY ZA; KASISKE BL
      POSTTRANSPLANT HYPERLIPIDEMIA - MECHANISMS AND MANAGEMENT

      Journal of the American Society of Nephrology
    83. IRISH AB; THOMPSON CH
      THE EFFECTS OF GEMFIBROZIL UPON THE HYPERCOAGULABLE STATE IN DYSLIPIDEMIC PATIENTS WITH CHRONIC-RENAL-FAILURE

      Nephrology, dialysis, transplantation
    84. GUNDUZ Z; DUSUNSEL R; KOSE K; UTAS C; DOGAN P
      THE EFFECTS OF DIALYZER REUSE ON PLASMA ANTIOXIDATIVE MECHANISMS IN PATIENTS ON REGULAR HEMODIALYSIS-TREATMENT

      Free radical biology & medicine
    85. LUBBECKE F; MATTHIAS FR; RICHTER U; FRETTLOH A; KATZ N; WIZEMANN V; SCHUTTERLE G
      CORONARY RISK-FACTORS IN PATIENTS WITH TE RMINAL RENAL-INSUFFICIENCY

      Medizinische Klinik
    86. PASCAZIO L; BIANCO F; GIORGINI A; GALLI G; CURRI G; PANZETTA G
      ECHO COLOR DOPPLER IMAGING OF CAROTID VESSELS IN HEMODIALYSIS-PATIENTS - EVIDENCE OF HIGH-LEVELS OF ATHEROSCLEROTIC LESIONS

      American journal of kidney diseases
    87. WALSER M; HILL S; TOMALIS EA
      TREATMENT OF NEPHROTIC ADULTS WITH A SUPPLEMENTED, VERY LOW-PROTEIN DIET

      American journal of kidney diseases
    88. ONEAL D; LEE P; MURPHY B; BEST J
      LOW-DENSITY-LIPOPROTEIN PARTICLE-SIZE DISTRIBUTION IN END-STAGE RENAL-DISEASE TREATED WITH HEMODIALYSIS OR PERITONEAL-DIALYSIS

      American journal of kidney diseases
    89. MITTMAN N; AVRAM MM
      DYSLIPIDEMIA IN RENAL-DISEASE

      Seminars in nephrology
    90. ATTMAN PO; SAMUELSSON O; ALAUPOVIC P
      DIAGNOSIS AND CLASSIFICATION OF DYSLIPIDEMIA IN RENAL-DISEASE

      Blood purification
    91. DINARDO A; SUGINO K; WERTZ P; ADEMOLA J; MAIBACH HI
      SODIUM LAURYL SULFATE (SLS) INDUCED IRRITANT CONTACT-DERMATITIS - A CORRELATION STUDY BETWEEN CERAMIDES AND IN-VIVO PARAMETERS OF IRRITATION

      Contact dermatitis
    92. VAZIRI ND; LIANG KH
      DOWN-REGULATION OF TISSUE LIPOPROTEIN-LIPASE EXPRESSION IN EXPERIMENTAL CHRONIC-RENAL-FAILURE

      Kidney international
    93. TSUKAMOTO Y; KOKUBO T; HORII A; MORIYA R; KOBAYASHI Y
      LIPOPROTEIN DERANGEMENT DURING STEROID TREATMENT IN MINIMAL-CHANGE NEPHROTIC SYNDROME

      Nephron
    94. BARBAGALLO CA; AVERNA MR; SPARACINO V; CEFALU AB; CAPUTO F; NOTO D; VERGHI F; NOTARBARTOLO A; BARBAGALLO CM
      HDL SUBFRACTIONS DISTRIBUTION IN RENAL-TRANSPLANT RECIPIENTS - LACK OF EVIDENCE OF A REDUCTION OF HDL(2) PARTICLES

      Nephron
    95. AMADOTTIR M; DALLONGEVILLE J; FRUCHART JC; NILSSONEHLE P
      VERY-LOW-DENSITY LIPOPROTEIN OF UREMIC PATIENTS IS A POOR SUBSTRATE FOR BOVINE LIPOPROTEIN-LIPASE IN-VITRO

      Metabolism, clinical and experimental
    96. ODETTI P; GARIBALDI S; GURRERI G; ARAGNO I; DAPINO D; PRONZATO MA; MARINARI UM
      PROTEIN OXIDATION IN HEMODIALYSIS AND KIDNEY-TRANSPLANTATION

      Metabolism, clinical and experimental
    97. EMENAKER NJ; DISILVESTRO RA; NAHMAN NS; PERCIVAL S
      COPPER-RELATED BLOOD INDEXES IN KIDNEY DIALYSIS PATIENTS

      The American journal of clinical nutrition
    98. EFSTRATIADIS G; FERNANDO R; NAIR D; JARUBA J; VARGHESE Z; MOORHEAD J
      THE EFFECT OF CYCLOSPORINE-A ON LDL BINDING BY HUMAN FIBROBLASTS

      JN. Journal of nephrology
    99. ELLIS D; ORCHARD TJ; LOMBARDOZZI S; YUNIS EJ; MCCAULEY J; AGOSTINI R; DIAMOND JR
      ATYPICAL HYPERLIPIDEMIA AND NEPHROPATHY ASSOCIATED WITH APOLIPOPROTEIN-E HOMOZYGOSITY

      Journal of the American Society of Nephrology
    100. BLANKESTIJN PJ; VOS PF; RABELINK TJ; VANRIJN HJM; JANSEN H; KOOMANS HA
      HIGH-FLUX DIALYSIS MEMBRANES IMPROVE LIPID PROFILE IN CHRONIC-HEMODIALYSIS PATIENTS

      Journal of the American Society of Nephrology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 29/05/20 alle ore 03:54:02